Swine influenza vaccines: current status and future perspectives (Q37749889)

22 August 2017

1 reference

title

Swine influenza vaccines: current status and future perspectives (English)

1 reference

22 August 2017

1 reference

1 reference

Wenjun Ma

1

1 reference

22 August 2017

Jürgen A Richt

series ordinal

2

1 reference

22 August 2017

publication date

13 May 2010

1 reference

Animal Health Research Reviews

22 August 2017

published in

1 reference

22 August 2017

volume

11

1 reference

22 August 2017

issue

1

1 reference

22 August 2017

page(s)

81-96

1 reference

Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Humoral and cellular immune responses following vaccination with purified recombinant hemagglutinin from influenza A (H3N2) virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Vaccination against equine influenza: quid novi?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Large outbreak of swine influenza in southern Japan caused by reassortant (H1N2) influenza viruses: its epizootic background and characterization of the causative viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Virologic and serologic surveillance for human, swine and avian influenza virus infections among pigs in the north-central United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

The emergence of novel swine influenza viruses in North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Preclinical evaluation of a modified vaccinia virus Ankara (MVA)-based vaccine against influenza A/H5N1 viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

DNA vaccination against influenza viruses: a review with emphasis on equine and swine influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

MVA-based H5N1 vaccine affords cross-clade protection in mice against influenza A/H5N1 viruses at low doses and after single immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Evaluation of the safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6-59 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

DNA vaccines against influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Potential for transmission of avian influenza viruses to pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Genetic characterization of H1N2 influenza A viruses isolated from pigs throughout the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Influenza vaccines based on virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Phylogenetic analysis of an H1N2 influenza A virus isolated from a pig in Korea. Brief Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Pathogenesis of Venezuelan Equine Encephalitis Virus Infection in Mice and Hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Innate sensors of influenza virus: clues to developing better intranasal vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

The prevalence of influenza viruses in swine and the antigenic and genetic relatedness of influenza viruses from man and swine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Baculovirus vector as a delivery vehicle for influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Influenza virus-like particle vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Influenza A Virus Lacking the NS1 Gene Replicates in Interferon-Deficient Systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Vaccines that facilitate antigen entry into dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Human infection with highly pathogenic H5N1 influenza virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Vaccination with DNA encoding internal proteins of influenza virus does not require CD8(+) cytotoxic T lymphocytes: either CD4(+) or CD8(+) T cells can promote survival and recovery after challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Different evolutionary trajectories of European avian-like and classical swine H1N1 influenza A viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Protection against filovirus infection: virus-like particle vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Prospects for developing an effective particle-mediated DNA vaccine against influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Sindbis virus: an efficient, broad host range vector for gene expression in animal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

A live attenuated H1N1 M1 mutant provides broad cross-protection against influenza A viruses, including highly pathogenic A/Vietnam/1203/2004, in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Innate immunity to influenza virus: implications for future therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

A viral polymerase involved in recognition of influenza virus-infected cells by a cytotoxic T-cell clone

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Current status of live attenuated influenza virus vaccine in the US.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

A novel recombinant virus-like particle vaccine for prevention of porcine parvovirus-induced reproductive failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

FluBlok, a next generation influenza vaccine manufactured in insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Evaluation of modified vaccinia virus Ankara as an alternative vaccine against smallpox in chronically HIV type 1-infected individuals undergoing HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

PB1-F2, an influenza A virus-encoded proapoptotic mitochondrial protein, creates variably sized pores in planar lipid membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Isolation and characterization of a Sagiyama virus from domestic pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Maternal immunization with both hemagglutinin- and neuraminidase-expressing DNAs provides an enhanced protection against a lethal influenza virus challenge in infant and adult mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Influenza viral infection of swine in the United States 1988?1989

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Genetic reassortment between avian and human influenza A viruses in Italian pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Novel reassortant of swine influenza H1N2 virus in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Influenza vaccine: the challenge of antigenic drift.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

A recombinant pseudorabies virus expressing rabies virus glycoprotein: safety and immunogenicity in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Antigenic and genetic analyses of H1N1 influenza A viruses from European pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Isolation and genetic characterization of avian-like H1N1 and novel ressortant H1N2 influenza viruses from pigs in China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Genetic evolution of swine influenza A (H3N2) viruses in China from 1970 to 2006

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

The epidemiology and evolution of influenza viruses in pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Derivation and characterization of a live attenuated equine influenza vaccine virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Evaluation of a recombinant human adenovirus-5 vaccine administered via needle-free device and intramuscular injection for vaccination of pigs against swine influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

H5N1 outbreaks and enzootic influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

The importance of animal influenza for human disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Multiple lineages of antigenically and genetically diverse influenza A virus co-circulate in the United States swine population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Evolution of swine H3N2 influenza viruses in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Recombinant modified vaccinia virus Ankara expressing a soluble form of glycoprotein B causes durable immunity and neutralizing antibodies against multiple strains of human cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Efficacy of inactivated swine influenza virus vaccines against the 2009 A/H1N1 influenza virus in pigs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Characterization of a newly emerged genetic cluster of H1N1 and H1N2 swine influenza virus in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Swine influenza viruses a North American perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Seroprevalence of H1N1, H3N2 and H1N2 influenza viruses in pigs in seven European countries in 2002-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Genetic relationships, serological cross-reaction and cross-protection between H1N2 and other influenza A virus subtypes endemic in European pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Protection against a European H1N2 swine influenza virus in pigs previously infected with H1N1 and/or H3N2 subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Isolations of H1N2 influenza A virus from pigs in Belgium

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Differentiation of serum antibodies from pigs vaccinated or infected with Aujeszky's disease virus by a competitive enzyme immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Evaluation of a recombinant hemagglutinin expressed in insect cells as an influenza vaccine in young and elderly adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Cytotoxic T cell recognition of the influenza nucleoprotein and hemagglutinin expressed in transfected mouse L cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

A recombinant pseudorabies virus encoding the HA gene from H3N2 subtype swine influenza virus protects mice from virulent challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Pseudorabies virus as a live virus vector for expression of foreign genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Swine influenza virus: zoonotic potential and vaccination strategies for the control of avian and swine influenzas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Recombinant adenovirus encoding the HA gene from swine H3N2 influenza virus partially protects mice from challenge with heterologous virus: A/HK/1/68 (H3N2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Eradication of Aujeszky's disease in Germany.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Host range restricted, non-replicating vaccinia virus vectors as vaccine candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Single inoculation of replication-defective adenovirus-vectored vaccines at birth in piglets with maternal antibodies induces high level of antibodies and protection against pseudorabies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Development of a simple and high-yielding fed-batch process for the production of influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

HLA B37 determines an influenza A virus nucleoprotein epitope recognized by cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Induction of neutralising antibodies by virus-like particles harbouring surface proteins from highly pathogenic H5N1 and H7N1 influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

A new approach to an influenza live vaccine: modification of the cleavage site of hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

A Virus Obtained from Influenza Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Novel swine influenza virus subtype H3N1, United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Systemic and mucosal immune responses to H1N1 influenza virus infection in pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Effects of DNA dose, route of vaccination, and coadministration of porcine interleukin-6 DNA on results of DNA vaccination against influenza virus infection in pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Up to new tricks - a review of cross-species transmission of influenza A viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Hong Kong A-2 Influenza Virus Infection among Swine during a Human Epidemic in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Recombinant modified vaccinia virus Ankara expressing the hemagglutinin gene confers protection against homologous and heterologous H5N1 influenza virus infections in macaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

SWINE INFLUENZA : III. FILTRATION EXPERIMENTS AND ETIOLOGY.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Influenza virus (A/HK/156/97) hemagglutinin expressed by an alphavirus replicon system protects chickens against lethal infection with Hong Kong-origin H5N1 viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Innate immune control and regulation of influenza virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Source for influenza pandemics

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

A novel intranasal virus-like particle (VLP) vaccine designed to protect against the pandemic 1918 influenza A virus (H1N1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Elastase-dependent live attenuated swine influenza A viruses are immunogenic and confer protection against swine influenza A virus infection in pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Reverse genetics-generated elastase-dependent swine influenza viruses are attenuated in pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Adaptation and Growth Characteristics of Influenza Virus at 25° C

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

The role of swine in the generation of novel influenza viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

A trivalent virus-like particle vaccine elicits protective immune responses against seasonal influenza strains in mice and ferrets

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Candidate influenza vaccines based on recombinant modified vaccinia virus Ankara.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Recognition of the PB1, neuraminidase, and matrix proteins of influenza virus A/NT/60/68 by cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Alphavirus vectors and vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Attenuated modified vaccinia virus Ankara can be used as an immunizing agent under conditions of preexisting immunity to the vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Genetic characterization of novel reassortant H1N2 influenza A viruses isolated from pigs in southeastern China

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Isolation and genetic characterization of new reassortant H3N1 swine influenza virus from pigs in the midwestern United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Immunization of non-human primates with DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Emergence of European avian influenza virus-like H1N1 swine influenza A viruses in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

A new generation of animal cell expression vectors based on the Semliki Forest virus replicon

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Respiratory and systemic humoral and cellular immune responses of pigs to a heterosubtypic influenza A virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Multiple genetic reassortment of avian and human influenza A viruses in European pigs, resulting in the emergence of an H1N2 virus of novel genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

A new modified live equine influenza virus vaccine: phenotypic stability, restricted spread and efficacy against heterologous virus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

Therapeutic vaccination with MVA-HIV-1 nef elicits Nef-specific T-helper cell responses in chronically HIV-1 infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

7 January 2021

Use of DNA encoding influenza hemagglutinin as an avian influenza vaccine

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

7 January 2021

Immunization of pigs with a particle-mediated DNA vaccine to influenza A virus protects against challenge with homologous virus

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

7 January 2021

Epidermal DNA vaccine for influenza is immunogenic in humans

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

7 January 2021

Molecular basis for the generation in pigs of influenza A viruses with pandemic potential

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

7 January 2021

Alphavirus replicon particle vaccines developed for use in humans induce high levels of antibodies to influenza virus hemagglutinin in swine: proof of concept

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

7 January 2021

Efficacy of a cold-adapted, intranasal, equine influenza vaccine: challenge trials

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

7 January 2021

Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

7 January 2021

Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

7 January 2021

In vivo gene transfer to skin and wound by microseeding

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

7 January 2021

A herpesvirus vector for expression of glycosylated membrane antigens: fusion proteins of pseudorabies virus gIII and human immunodeficiency virus type 1 envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

7 January 2021

Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera

1 reference

https://api.crossref.org/works/10.1017%2FS146625231000006X

7 January 2021

10.1017/S146625231000006X

Identifiers

DOI

1 reference

22 August 2017

1 reference